CD36 in atherosclerosis: pathophysiological mechanisms and therapeutic implications

K Tian, Y Xu, A Sahebkar, S Xu - Current atherosclerosis reports, 2020 - Springer
Abstract Purpose of Review Atherosclerosis is a chronic disease characterized by lipid
retention and inflammation in the artery wall. The retention and oxidation of low-density …

[HTML][HTML] Recent advances in the development of theranostic nanoparticles for cardiovascular diseases

Y Wu, KX Vazquez-Prada, Y Liu, AK Whittaker… - …, 2021 - ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD includes a
group of disorders of the heart and blood vessels such as myocardial infarction, ischemic …

Endothelial dysfunction and cardiovascular disease: History and analysis of the clinical utility of the relationship

PJ Little, CD Askew, S Xu, D Kamato - Biomedicines, 2021 - mdpi.com
The endothelium is the single-cell monolayer that lines the entire vasculature. The
endothelium has a barrier function to separate blood from organs and tissues but also has …

Chitosan nanococktails containing both ceria and superparamagnetic iron oxide nanoparticles for reactive oxygen species-related theranostics

Y Wu, R Zhang, HDN Tran, ND Kurniawan… - ACS Applied Nano …, 2021 - ACS Publications
Reactive oxygen species (ROS) play an essential role in the progression of many chronic
diseases like atherosclerosis and rheumatoid arthritis. For decades, antioxidant compounds …

Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling

ZJ Chia, H Kumarapperuma, R Zhang… - Acta Pharmacologica …, 2024 - nature.com
The Smad transcription factors are well known for their role at the core of transforming
growth factor-β (TGF-β) signalling. However, recent evidence shows that the Smad …

The role of toll-like receptors in atherothrombotic cardiovascular disease

Y Zhou, PJ Little, L Downey, R Afroz, Y Wu… - ACS Pharmacology & …, 2020 - ACS Publications
Toll-like receptors (TLRs) are dominant components of the innate immune system. Activated
by both pathogen-associated molecular patterns and damage-associated molecular …

Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling

D Kamato, BH Do, N Osman, BP Ross… - Cellular and Molecular …, 2020 - Springer
Transforming growth factor (TGF)-β signalling pathways are intensively investigated
because of their diverse association with physiological and pathophysiological states. Smad …

[HTML][HTML] Response to retention hypothesis as a source of targets for arterial wall-Directed therapies to prevent atherosclerosis: A critical review

H Kumarapperuma, ZJ Chia, SM Malapitan, TN Wight… - Atherosclerosis, 2024 - Elsevier
The subendothelial retention of circulating lipoproteins on extracellular matrix proteins and
proteoglycans is one of the earliest events in the development of atherosclerosis. Multiple …

Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis

MTLC Lhoëst, A Martinez, L Claudi… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
In recent years, the role of macrophages as the primary cell type contributing to foam cell
formation and atheroma plaque development has been widely acknowledged. However, it …

Transforming growth factor–β1 mediated CHST11 and CHSY1 mRNA expression is ROS dependent in vascular smooth muscle cells

R Mohamed, P Dayati, RN Mehr, D Kamato… - Journal of cell …, 2019 - Springer
Transforming growth factor (TGF)-β1 mediates glycosaminoglycan (GAG) chain
hyperelongation on secreted proteoglycans and these modifications are associated with …